D. Scott Coward
CIK: 0001247296
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 6, 2026HUMA
Humacyte, Inc.
Award(A)DirectStock Options (right to buy)
125K shares- - Mar 23, 2026EXAS
EXACT SCIENCES CORP
Disposition(D)Direct52.2K shares- - Mar 23, 2026EXAS
EXACT SCIENCES CORP
Disposition(D)Direct5.4K shares- - Mar 23, 2026EXAS
EXACT SCIENCES CORP
Disposition(D)Indirect4.7K shares- - Jun 12, 2025EXAS
EXACT SCIENCES CORP
Award(A)Direct5.4K shares- - Feb 19, 2025EXAS
EXACT SCIENCES CORP
Exercise(M)Direct2.2K shares- - Feb 19, 2025EXAS
EXACT SCIENCES CORP
Tax Payment(F)Direct667 shares at avg. $49.63$33K - Jun 13, 2024EXAS
EXACT SCIENCES CORP
Award(A)Direct5.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 |  HUMA Humacyte, Inc. | Award(A) Stock Options (right to buy) | 125,000 | - | - | Direct |
| Mar 23, 2026 |  EXAS EXACT SCIENCES CORP | Disposition(D) | 52,164 | - | $0 | Direct |
| Mar 23, 2026 | EXAS EXACT SCIENCES CORP | Disposition(D) | 5,398 | - | $0 | Direct |
| Mar 23, 2026 | EXAS EXACT SCIENCES CORP | Disposition(D) | 4,694 | - | $0 | Indirect |
| Jun 12, 2025 | EXAS EXACT SCIENCES CORP | Award(A) | 5,398 | - | - | Direct |
| Feb 19, 2025 | EXAS EXACT SCIENCES CORP | Exercise(M) | 2,248 | - | - | Direct |
| Feb 19, 2025 | EXAS EXACT SCIENCES CORP | Tax Payment(F) | 667 | $49.63 | $33,103 | Direct |
| Jun 13, 2024 | EXAS EXACT SCIENCES CORP | Award(A) | 5,939 | - | $0 | Direct |
1-8 of 8 transactions
About COWARD D SCOTT
COWARD D SCOTT (SEC CIK 0001247296) files insider reports with the SEC as Director of Humacyte, Inc. (HUMA) and Director of EXACT SCIENCES CORP (EXAS).
Signal8 holds 6 ownership filings by COWARD D SCOTT (1 Form 3, 5 Form 4), filed between Dec 20, 2024 and Oct 7, 2026. Those filings report 8 transactions, from Jun 13, 2024 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on COWARD D SCOTT's filings is in DURHAM, NC.
Recent filings by COWARD D SCOTT
- Oct 6, 2026: Grant or award of HUMA derivative securities (Form 4, code A).
- Mar 23, 2026: Disposition to issuer transactions of EXAS shares (3 lines, Form 4, code D).
- Jun 12, 2025: Grant or award of EXAS shares (Form 4, code A).
- Feb 19, 2025: Option exercise of EXAS shares (Form 4, code M).
- Feb 19, 2025: Tax withholding of EXAS shares (Form 4, code F).
Other insiders filing for Humacyte, Inc. (HUMA)
- Kuznik Paul Brian, Director
- Jones Keith Anthony, Director
- Windham-Bannister Susan Richards, Director
- Constantino Michael T., Director
- Wallace Max N., Director
- Niklason Laura E, President, CEO and Director